EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Effects of Glycyrrhizic Acid on Dry Eye Disease: Targeting Pyroptosis, Oxidative Stress, and Epithelial Barrier Dysfunction

Yiran Chu iD, Chengxiao Zhang iD, Zeying Chen, Qi Zhang, Yun Tang iD, Jiaxuan Jiang, Kai Hu

International Journal of Molecular Sciences · 06.05.2026 · 27 (9) · 4153

DOI: 10.3390/ijms27094153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.05.2026. Verfasst von Yiran Chu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing 2100…. Hauptthemen laut MEDLINE: Glycyrrhizic Acid, Oxidative Stress, Dry Eye Syndromes, Epithelium, Corneal. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, General Program of The Health Commission of Nanjing City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED) is a common ocular surface disorder characterized by instability of the tear film, inflammatory responses, and epithelial damage, and therapeutic interventions directed at these fundamental pathogenetic processes are still insufficient. This research aimed to evaluate the medicinal efficacy of glycyrrhizic acid (GA) and to unravel the underlying molecular pathways through which it exerts its protective role in DED. A benzalkonium chloride-induced mouse model and a hyperosmolarity-induced human corneal epithelial cell model were established. Corneal epithelial injury, tear secretion, and goblet cell density were evaluated in vivo, while cellular responses and related signaling pathways were examined using RT-qPCR, Western blotting, flow cytometry, and immunofluorescence. GA treatment alleviated corneal epithelial damage, increased tear secretion, and improved goblet cell density in mice. In vitro, GA reduced inflammatory responses, as evidenced by decreased tumor necrosis factor-α (TNF-α) expression, and helped preserve epithelial barrier integrity, accompanied by reduced matrix metalloprotease 9 (MMP9) levels. Further analysis suggested that GA suppressed pyroptosis through regulation of the high mobility group box 1 (HMGB1)/lysosomal membrane permeabilization (LMP)/cathepsin B (CTSB) pathway and attenuated oxidative stress via activation of the nuclear factor erythroid 2–related factor 2 (Nrf2)/heme oxygenase-1 (HO-1)/NAD (P)H:quinone oxidoreductase 1 (NQO1) axis. In addition, GA improved mitochondrial function, as indicated by decreased reactive oxygen species levels, restored membrane potential, and enhanced adenosine triphosphate (ATP) production. Taken together, these findings indicate that GA may alleviate hyperosmolarity-induced DED by modulating inflammation, oxidative stress, mitochondrial dysfunction, and epithelial barrier damage, underscoring its viability as a remedial candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhizic AcidOxidative StressDry Eye SyndromesEpithelium, CornealPyroptosisAnimalsHumansMiceReactive Oxygen SpeciesDisease Models, AnimalAnti-Inflammatory AgentsEpithelial Cells

Stichwörter der Autor:innen

dry eye diseaseepithelial barrier dysfunctionglycyrrhizic acidoxidative stresspyroptosis

Substanzen

Glycyrrhizic AcidReactive Oxygen SpeciesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing 210008, China.
  • Department of Ophthalmology, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, 321 Zhongshan Road, Nanjing 210008, China.

ORCID-Profile: Yiran Chu, Chengxiao Zhang, Yun Tang

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • General Program of The Health Commission of Nanjing City
  • Clinical Trials from Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

Zitieren

APA

Chu, Y., Zhang, C., Chen, Z., Zhang, Q., Tang, Y., Jiang, J., & Hu, K. (2026). Therapeutic Effects of Glycyrrhizic Acid on Dry Eye Disease: Targeting Pyroptosis, Oxidative Stress, and Epithelial Barrier Dysfunction. International Journal of Molecular Sciences, 27(9), 4153. https://doi.org/10.3390/ijms27094153

Vancouver

Chu Y, Zhang C, Chen Z, Zhang Q, Tang Y, Jiang J, et al. Therapeutic Effects of Glycyrrhizic Acid on Dry Eye Disease: Targeting Pyroptosis, Oxidative Stress, and Epithelial Barrier Dysfunction. International Journal of Molecular Sciences. 2026;27(9):4153. doi:10.3390/ijms27094153

BibTeX
@article{Chu2026,
  author = {Chu, Yiran and Zhang, Chengxiao and Chen, Zeying and Zhang, Qi and Tang, Yun and Jiang, Jiaxuan and Hu, Kai},
  title = {Therapeutic Effects of Glycyrrhizic Acid on Dry Eye Disease: Targeting Pyroptosis, Oxidative Stress, and Epithelial Barrier Dysfunction},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {4153},
  doi = {10.3390/ijms27094153}
}
Kostenlos starten →